BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/24/2022 10:56:44 AM | Browse: 252 | Download: 427
 |
Received |
|
2022-03-13 10:04 |
|
Peer-Review Started |
|
2022-03-13 10:06 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-04-13 11:41 |
|
Revised |
|
2022-04-25 11:00 |
|
Second Decision |
|
2022-06-17 03:04 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-06-20 17:34 |
|
Articles in Press |
|
2022-06-20 17:34 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-07-25 09:06 |
|
Typeset the Manuscript |
|
2022-09-16 05:50 |
|
Publish the Manuscript Online |
|
2022-09-24 10:56 |
| ISSN |
2220-3249 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Virology |
| Manuscript Type |
Review |
| Article Title |
Association of COVID-19 with hepatic metabolic dysfunction
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ramesh Kumar, Vijay Kumar, Rahul Arya, Utpal Anand and Rajeev Nayan Priyadarshi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ramesh Kumar, MD, Associate Professor, Department of Gastroenterology, All India Institute of Medical Sciences, Patna, Phulwari Sharif, Patna 801507, Bihar, India. docrameshkr@gmail.com |
| Key Words |
COVID-19; Coronavirus; Metabolism; Metabolic syndrome; Metabolic inflammation; Hepatic dysfunction |
| Core Tip |
In coronavirus disease 2019 (COVID-19) patients, the virus induces a complex viral-host interaction that leads to metabolic reprogramming, altered immunological responses, and a variety of clinical consequences. In metabolomic and lipidomic studies, a variety of alterations in amino acids, lipids, carbohydrates, and energy metabolism have been identified in such patients. The liver is the primary metabolic organ; thus, these metabolic alterations may have a major impact on patients with liver diseases and metabolic comorbidities that are common in COVID-19 patients. Therefore, this review article discusses the pathophysiological aspects and clinical implications of metabolic dysfunction in COVID-19 patients with a focus on the liver. |
| Publish Date |
2022-09-24 10:56 |
| Citation |
Kumar R, Kumar V, Arya R, Anand U, Priyadarshi RN. Association of COVID-19 with Hepatic Metabolic Dysfunction. World J Virol 2022; 11(5): 237-251 |
| URL |
https://www.wjgnet.com/2220-3249/full/v11/i5/237.htm |
| DOI |
https://dx.doi.org/10.5501/wjv.v11.i5.237 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
